Presentation is loading. Please wait.

Presentation is loading. Please wait.

Can Fontan Conversion for Patients Without Late Fontan Complications be Justified?  Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi.

Published byWilfrid Maxwell Modified over 5 years ago

Similar presentations

Presentation on theme: "Can Fontan Conversion for Patients Without Late Fontan Complications be Justified?  Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi."— Presentation transcript:

1 Can Fontan Conversion for Patients Without Late Fontan Complications be Justified? 
Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi Shimada, MD, Hideo Ohuchi, MD, PhD, Isao Shiraishi, MD, PhD, Hajime Ichikawa, MD, PhD  The Annals of Thoracic Surgery  Volume 103, Issue 6, Pages (June 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Actual survival rates estimated by the Kaplan-Meier method. The dashed line represents group 1, the solid line represents group 2, and the dotted line represents all patients. No significant difference between group 1 and group 2 was detected by the log-rank test (p = 0.12). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Freedom from (A) atrial tachyarrhythmia (AT) rate and (B) protein-losing enteropathy (PLE) rate in both groups. The dashed lines represent group 1 and the solid lines represent group 2. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Postoperative chronological changes of (A) the mean pulmonary arterial pressure (PAP), (B) systemic ventricular end-diastolic pressure (SVEDP), and (C) cardiac index calculated by cardiac catheter examination. The dashed line represents group 1 and the solid line represents group 2. *p < 0.05. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Postoperative chronological changes of (A) systemic ventricular end-diastolic volume index (SVEDVI), (B) systemic ventricular end-systolic volume (SVESVI), (C) stroke volume index (SVI), and (D) systemic ventricular ejection fraction (SVEF) calculated by cardiac catheter examination. The dashed lines represent group 1 and the solid lines represent group 2. *p < 0.05. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 The changes in (A) New York Heart Association (NYHA) functional class and (B) peak oxygen consumption (VO2) from preoperative evaluation (pre) to 1 year after the conversion (1 year). The dashed lines and closed circles represent group 1 and the solid lines and open circles represent group 2. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Can Fontan Conversion for Patients Without Late Fontan Complications be Justified?  Akihiko Higashida, MD, Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Masatoshi."

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease  Srikrishna Sirivella, MD, Isaac Gielchinsky,
Anna Hallbergson, MD, PhD, Kimberlee Gauvreau, ScD, Andrew J

Anna Hallbergson, MD, PhD, Kimberlee Gauvreau, ScD, Andrew J
Clinical Outcomes of Mitral Valve Replacement With the 16-mm ATS Advanced Performance Valve in Neonates and Infants  Jiyong Moon, MD, Takaya Hoashi, MD,

Clinical Outcomes of Mitral Valve Replacement With the 16-mm ATS Advanced Performance Valve in Neonates and Infants  Jiyong Moon, MD, Takaya Hoashi, MD,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction  Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.
Mortality and Morbidity After Total Aortic Arch Replacement

Mortality and Morbidity After Total Aortic Arch Replacement
Late Vascular Complications After Extracorporeal Membrane Oxygenation Support  Daniel Zimpfer, MD, Birgit Heinisch, MD, Martin Czerny, MD, Thomas Hoelzenbein,

Late Vascular Complications After Extracorporeal Membrane Oxygenation Support  Daniel Zimpfer, MD, Birgit Heinisch, MD, Martin Czerny, MD, Thomas Hoelzenbein,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Anatomic Repair for Corrected Transposition With Left Ventricular Outflow Tract Obstruction  Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Aya Miyazaki,

Anatomic Repair for Corrected Transposition With Left Ventricular Outflow Tract Obstruction  Takaya Hoashi, MD, PhD, Koji Kagisaki, MD, Aya Miyazaki,
Clinical Outcomes of Mitral Valve Replacement With the 16-mm ATS Advanced Performance Valve in Neonates and Infants  Jiyong Moon, MD, Takaya Hoashi, MD,

Clinical Outcomes of Mitral Valve Replacement With the 16-mm ATS Advanced Performance Valve in Neonates and Infants  Jiyong Moon, MD, Takaya Hoashi, MD,
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy  Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy  Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A

B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A
Biventricular Repair for Right Atrial Isomerism

Biventricular Repair for Right Atrial Isomerism
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Similar presentations

Ads by Google